Overview

A Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2025-08-01
Target enrollment:
Participant gender:
Summary
A randomized, double-blind, placebo-controlled, multicenter, phase III clinical study of the efficacy and safety of two low-concentration atropine sulfate eye drops in slowing the progression of myopia in children
Phase:
PHASE3
Details
Lead Sponsor:
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
Treatments:
Atropine